Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BOSTON SCIENTIFIC CORP Director's Dealing 2015

Jun 1, 2015

29821_dirs_2015-06-01_1472d3b4-07bb-429c-a66c-730bd0da013c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2015-05-28

Reporting Person: Carruthers Wendy (SVP, Human Resources)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-05-28 Common Stock M 33512.0000 $8.3000 Acquired 77096.0000 Direct
2015-05-28 Common Stock M 8769.0000 $7.7400 Acquired 85865.0000 Direct
2015-05-28 Common Stock S 42281.0000 $17.9100 Disposed 43584.0000 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2015-05-28 Stock Option (Right to Buy) $8.3000 M 33512.0000 Disposed 2019-02-24 Common Stock (33512.0000) Direct
2015-05-28 Stock Option (Right to Buy) $7.7400 M 8769.0000 Disposed 2020-02-26 Common Stock (8769.0000) Direct

Footnotes

F1: Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available.

F2: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in whole on February 24, 2013, the fourth anniversary of the date of grant.

F3: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in whole on February 26, 2014, the fourth anniversary of the date of grant.